NLRP1 and colorectal cancer: Studies have shown that the mRNA and protein levels of NLRP1 are reduced in colorectal cancer cells compared to normal cells and the anticancer drug DAC increases the expression of NLRP1 to inhibit the progression of colorectal cancer (29, 30).